NPPNY
Price
$9.29
Change
-$0.23 (-2.42%)
Updated
Dec 26 closing price
Capitalization
2.49B
Intraday BUY SELL Signals
OILFF
Price
$0.04
Change
-$0.00 (-0.00%)
Updated
Dec 26 closing price
Capitalization
6.15M
Intraday BUY SELL Signals
Interact to see
Advertisement

NPPNY vs OILFF

Header iconNPPNY vs OILFF Comparison
Open Charts NPPNY vs OILFFBanner chart's image
Nippon Shinyaku
Price$9.29
Change-$0.23 (-2.42%)
Volume$431
Capitalization2.49B
NEXTLEAF SOLUTIONS
Price$0.04
Change-$0.00 (-0.00%)
Volume$18.59K
Capitalization6.15M
NPPNY vs OILFF Comparison Chart in %
NPPNY
Daily Signal:
Gain/Loss:
OILFF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
NPPNY vs. OILFF commentary
Dec 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NPPNY is a Hold and OILFF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 28, 2025
Stock price -- (NPPNY: $9.29 vs. OILFF: $0.04)
Brand notoriety: NPPNY and OILFF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: NPPNY: 8% vs. OILFF: 12%
Market capitalization -- NPPNY: $2.49B vs. OILFF: $6.15M
NPPNY [@Pharmaceuticals: Generic] is valued at $2.49B. OILFF’s [@Pharmaceuticals: Generic] market capitalization is $6.15M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NPPNY’s FA Score shows that 3 FA rating(s) are green whileOILFF’s FA Score has 0 green FA rating(s).

  • NPPNY’s FA Score: 3 green, 2 red.
  • OILFF’s FA Score: 0 green, 5 red.
According to our system of comparison, NPPNY is a better buy in the long-term than OILFF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NPPNY’s TA Score shows that 4 TA indicator(s) are bullish while OILFF’s TA Score has 6 bullish TA indicator(s).

  • NPPNY’s TA Score: 4 bullish, 4 bearish.
  • OILFF’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, OILFF is a better buy in the short-term than NPPNY.

Price Growth

NPPNY (@Pharmaceuticals: Generic) experienced а -2.42% price change this week, while OILFF (@Pharmaceuticals: Generic) price change was -1.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.01%. For the same industry, the average monthly price growth was +6.35%, and the average quarterly price growth was +23.01%.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.01% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NPPNY($2.49B) has a higher market cap than OILFF($6.15M). NPPNY has higher P/E ratio than OILFF: NPPNY (12.24) vs OILFF (5.41). NPPNY YTD gains are higher at: 39.910 vs. OILFF (-21.126). NPPNY has higher annual earnings (EBITDA): 44.4B vs. OILFF (902K). NPPNY has more cash in the bank: 68.5B vs. OILFF (662K). OILFF has less debt than NPPNY: OILFF (347K) vs NPPNY (2.53B). NPPNY has higher revenues than OILFF: NPPNY (161B) vs OILFF (12.3M).
NPPNYOILFFNPPNY / OILFF
Capitalization2.49B6.15M40,465%
EBITDA44.4B902K4,922,395%
Gain YTD39.910-21.126-189%
P/E Ratio12.245.41226%
Revenue161B12.3M1,308,943%
Total Cash68.5B662K10,347,432%
Total Debt2.53B347K729,107%
FUNDAMENTALS RATINGS
NPPNY vs OILFF: Fundamental Ratings
NPPNY
OILFF
OUTLOOK RATING
1..100
2815
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
53
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
1381
PRICE GROWTH RATING
1..100
3565
P/E GROWTH RATING
1..100
3299
SEASONALITY SCORE
1..100
n/a2

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NPPNY's Valuation (18) in the null industry is somewhat better than the same rating for OILFF (53). This means that NPPNY’s stock grew somewhat faster than OILFF’s over the last 12 months.

NPPNY's Profit vs Risk Rating (100) in the null industry is in the same range as OILFF (100). This means that NPPNY’s stock grew similarly to OILFF’s over the last 12 months.

NPPNY's SMR Rating (13) in the null industry is significantly better than the same rating for OILFF (81). This means that NPPNY’s stock grew significantly faster than OILFF’s over the last 12 months.

NPPNY's Price Growth Rating (35) in the null industry is in the same range as OILFF (65). This means that NPPNY’s stock grew similarly to OILFF’s over the last 12 months.

NPPNY's P/E Growth Rating (32) in the null industry is significantly better than the same rating for OILFF (99). This means that NPPNY’s stock grew significantly faster than OILFF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NPPNYOILFF
RSI
ODDS (%)
Bearish Trend 3 days ago
47%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
51%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
36%
Bullish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
50%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
53%
Bullish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
28%
Bullish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 12 days ago
41%
Bullish Trend 7 days ago
87%
Declines
ODDS (%)
N/A
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
33%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
37%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
NPPNY
Daily Signal:
Gain/Loss:
OILFF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GSUN1.160.03
+2.65%
Golden Sun Health Technology Group Limited
GBDC13.550.13
+0.97%
Golub Capital BDC
AEE99.81-0.03
-0.03%
Ameren Corp
CDXS1.63-0.05
-2.98%
Codexis
KALV15.17-0.62
-3.93%
KalVista Pharmaceuticals

NPPNY and

Correlation & Price change

A.I.dvisor tells us that NPPNY and MEDIF have been poorly correlated (+11% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NPPNY and MEDIF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NPPNY
1D Price
Change %
NPPNY100%
-2.42%
MEDIF - NPPNY
11%
Poorly correlated
-1.64%
OVATF - NPPNY
10%
Poorly correlated
N/A
OMID - NPPNY
3%
Poorly correlated
-9.42%
OILFF - NPPNY
-1%
Poorly correlated
+9.72%
MKGAF - NPPNY
-1%
Poorly correlated
+2.59%
More

OILFF and

Correlation & Price change

A.I.dvisor tells us that OILFF and RDY have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OILFF and RDY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OILFF
1D Price
Change %
OILFF100%
+9.72%
RDY - OILFF
20%
Poorly correlated
+0.50%
OMID - OILFF
9%
Poorly correlated
-9.42%
MVMDF - OILFF
7%
Poorly correlated
N/A
PCLOF - OILFF
2%
Poorly correlated
+26.20%
OWPC - OILFF
-1%
Poorly correlated
+11.54%
More